Showing results (1851-1860 of 1,903) with videos related to

Sort By:
Pageof 191
Oncogenesis|March 4, 2021
Single-cell RNA sequencing reveals that targeting HSP90 suppresses PDAC progression by restraining mitochondrial bioenergeticsLi-Peng Hu, Kai-Xia Zhou, Yan-Miao Huo, et al.
Molecular Therapy. Nucleic Acids|November 16, 2022
Retraction Notice to: Long Noncoding RNA OIP5-AS1 Promotes the Progression of Liver Hepatocellular Carcinoma via Regulating the hsa-miR-26a-3p/EPHA2 AxisYu-Shui Ma, Kai-Jian Chu, Chang-Chun Ling, et al.
Lancet (London, England)|October 22, 2025
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trialZheng Wang, Jia Fan, Shaolai Zhou, et al.
Journal for Immunotherapy of Cancer|October 19, 2025
Stromal cells modulate innate immune cell phenotype and function in colorectal cancer via the Sialic acid/Siglec axisAoise O'Neill, Norashikin Zakaria, Courtney Bull, et al.
The Journal of Clinical Endocrinology and Metabolism|October 27, 2020
Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter StudyXiao-Jing Cao, Juan Liu, Ya-Lin Zhu, et al.
Oncogene|January 27, 2022
A low amino acid environment promotes cell macropinocytosis through the YY1-FGD6 axis in Ras-mutant pancreatic ductal adenocarcinomaYi-Fan Zhang, Qing Li, Pei-Qi Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2018
Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell GlycolysisLi-Peng Hu, Xiao-Xin Zhang, Shu-Heng Jiang, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 3, 2023
The SLITRK4-CNPY3 axis promotes liver metastasis of gastric cancer by enhancing the endocytosis and recycling of TrkB in tumour cellsYao-Qi Zhou, Tian-Shang Bao, Jia-Xuan Xie, et al.
ACS Medicinal Chemistry Letters|August 20, 2021
Discovery of VU6028418: A Highly Selective and Orally Bioavailable M4 Muscarinic Acetylcholine Receptor AntagonistMatthew Spock, Trever R Carter, Katrina A Bollinger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 10, 2025
The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021Ethan Kai Jun Tham, Darren Jun Hao Tan, Pojsakorn Danpanichkul, et al.
Pageof 191